Grace McArdle - Mar 1, 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
EVP, MANUFACTURING AND QUALITY
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Grace McArdle
Stock symbol
ELAN
Transactions as of
Mar 1, 2024
Transactions value $
-$30,794
Form type
4
Date filed
3/5/2024, 04:27 PM
Previous filing
Feb 29, 2024
Next filing
Jul 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +14.2K +33.29% $0.00 56.8K Mar 1, 2024 Direct F1
transaction ELAN Common Stock Tax liability -$30.8K -1.92K -3.38% $16.03 54.9K Mar 1, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option(right to buy) Award $0 +31K $0.00 31K Mar 1, 2024 Common Stock 31K $16.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
F2 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F3 Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.